Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Yuan

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
JTCVS Open|July 1, 2026
Physically validated mitral valve models for surgical simulation: Bridging anatomy, pathology, and practicePatrick Carnahan, Charles Yuan, John Moore, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 27, 2025
FDA Approval Summary: Axatilimab for Adult and Pediatric Patients Weighing at Least 40 Kilograms with Chronic GVHD after Two Prior Lines of Systemic TherapyRobert Q Le, Kamar Godder, Jingyan Wang, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
JTCVS Open|July 1, 2026
Physically validated mitral valve models for surgical simulation: Bridging anatomy, pathology, and practicePatrick Carnahan, Charles Yuan, John Moore, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 27, 2025
FDA Approval Summary: Axatilimab for Adult and Pediatric Patients Weighing at Least 40 Kilograms with Chronic GVHD after Two Prior Lines of Systemic TherapyRobert Q Le, Kamar Godder, Jingyan Wang, et al.
Pageof 1